Regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy-resistant MSS metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Fakih, Marwan
Sandhu, Jaideep Singh
Lim, Dean
Li, Sierra
Wang, Chongkai
机构：
[1] City Hope Natl Comprehens Canc Ctr, Duarte, CA USA
[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC)
    Fakih, M. G.
    Sandhu, J.
    Lim, D.
    Li, S. M.
    Wang, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S684 - S684
  • [2] Immune dynamics and response predictors to regorafenib, ipilimumab, and nivolumab (RIN) treatment in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Ye, Jian
    Wang, Chongkai
    Egelston, Colt
    Guo, Weihua
    Lee, Peter
    Fakih, Marwan
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Exploratory biomarker analyses in phase 1 study of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
    Ye, Jian
    Wang, Chongkai
    Egelston, Colt
    Guo, Weihua
    Lee, Peter P.
    Fakih, Marwan
    CANCER RESEARCH, 2023, 83 (07)
  • [4] A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
    Parikh, Aparna Raj
    Clark, Jeffrey William
    Wo, Jennifer Yon-Li
    Yeap, Beow Y.
    Allen, Jill N.
    Blaszkowsky, Lawrence Scott
    Ryan, David P.
    Giantonio, Bruce J.
    Weekes, Colin D.
    Zhu, Andrew X.
    Van Seventer, Emily E.
    Matlack, Lauren
    Foreman, Bronwen
    Ly, Leilana
    Drapek, Lorraine C.
    Ting, David Tsai
    Corcoran, Ryan Bruce
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Efficacy of chemotherapy after treatment with regorafenib in metastatic colorectal cancer (mCRC).
    Kidd, Michael Todd
    Wilcox, Ryan Eldredge
    Rogers, Jane
    Eng, Cathy
    Saadat, Siamak
    Lenz, Heinz-Josef
    Hubbard, Joleen Marie
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Nivolumab plus ipilimumab in metastatic colorectal cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (03): : E139 - E139
  • [7] Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer (mCRC).
    Wu, Tsung-Che
    Liang, Yi-Hsin
    Chen, Kuo-Hsing
    Chuang, Chien Huai
    Shao, Yu Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 36 - 36
  • [8] Chemotherapy-Resistant Metastatic Breast Cancer
    Marquette, Carrie
    Nabell, Lisle
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 263 - 275
  • [9] Chemotherapy-Resistant Metastatic Breast Cancer
    Carrie Marquette
    Lisle Nabell
    Current Treatment Options in Oncology, 2012, 13 : 263 - 275
  • [10] INTENSIVE CHEMOTHERAPY FOR METASTATIC COLORECTAL CANCER (MCRC)
    Ychou, M.
    ANNALS OF ONCOLOGY, 2013, 24
12345